Logo image of RVP

RETRACTABLE TECHNOLOGIES INC (RVP) Stock Fundamental Analysis

NYSEARCA:RVP - NYSE Arca - US76129W1053 - Common Stock - Currency: USD

0.7071  +0 (+0.27%)

After market: 0.71 +0 (+0.41%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to RVP. RVP was compared to 187 industry peers in the Health Care Equipment & Supplies industry. RVP scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. RVP is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

RVP had negative earnings in the past year.
RVP had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: RVP reported negative net income in multiple years.
RVP had a positive operating cash flow in 4 of the past 5 years.
RVP Yearly Net Income VS EBIT VS OCF VS FCFRVP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

RVP's Return On Assets of -15.44% is in line compared to the rest of the industry. RVP outperforms 54.55% of its industry peers.
RVP has a Return On Equity (-30.08%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -15.44%
ROE -30.08%
ROIC N/A
ROA(3y)-3.04%
ROA(5y)8.65%
ROE(3y)-5.56%
ROE(5y)18.57%
ROIC(3y)N/A
ROIC(5y)N/A
RVP Yearly ROA, ROE, ROICRVP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

1.3 Margins

RVP does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RVP Yearly Profit, Operating, Gross MarginsRVP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

More info and screens

5

2. Health

2.1 Basic Checks

RVP does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for RVP remains at a similar level compared to 1 year ago.
Compared to 5 years ago, RVP has less shares outstanding
RVP has a better debt/assets ratio than last year.
RVP Yearly Shares OutstandingRVP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
RVP Yearly Total Debt VS Total AssetsRVP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

RVP has an Altman-Z score of 0.48. This is a bad value and indicates that RVP is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.48, RVP is in line with its industry, outperforming 46.52% of the companies in the same industry.
A Debt/Equity ratio of 0.01 indicates that RVP is not too dependend on debt financing.
RVP's Debt to Equity ratio of 0.01 is fine compared to the rest of the industry. RVP outperforms 68.98% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 0.48
ROIC/WACCN/A
WACC8.91%
RVP Yearly LT Debt VS Equity VS FCFRVP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M 100M

2.3 Liquidity

RVP has a Current Ratio of 6.70. This indicates that RVP is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 6.70, RVP belongs to the best of the industry, outperforming 86.10% of the companies in the same industry.
RVP has a Quick Ratio of 4.47. This indicates that RVP is financially healthy and has no problem in meeting its short term obligations.
RVP has a Quick ratio of 4.47. This is in the better half of the industry: RVP outperforms 77.01% of its industry peers.
Industry RankSector Rank
Current Ratio 6.7
Quick Ratio 4.47
RVP Yearly Current Assets VS Current LiabilitesRVP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for RVP have decreased strongly by -193.85% in the last year.
Looking at the last year, RVP shows a very negative growth in Revenue. The Revenue has decreased by -16.05% in the last year.
RVP shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.59% yearly.
EPS 1Y (TTM)-193.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2944.35%
Revenue 1Y (TTM)-16.05%
Revenue growth 3Y-44.02%
Revenue growth 5Y-4.59%
Sales Q2Q%9.16%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RVP Yearly Revenue VS EstimatesRVP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

RVP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RVP Price Earnings VS Forward Price EarningsRVP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RVP Per share dataRVP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

RVP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

RETRACTABLE TECHNOLOGIES INC

NYSEARCA:RVP (7/25/2025, 8:23:39 PM)

After market: 0.71 +0 (+0.41%)

0.7071

+0 (+0.27%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-19 2025-05-19
Earnings (Next)08-18 2025-08-18
Inst Owners7.71%
Inst Owner Change-0.33%
Ins Owners57.63%
Ins Owner Change2.9%
Market Cap21.17M
Analysts0
Price TargetN/A
Short Float %0.19%
Short Ratio0.52
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.01
Dividend Growth(5Y)2.82%
DP-1%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.63
P/FCF N/A
P/OCF N/A
P/B 0.28
P/tB 0.28
EV/EBITDA N/A
EPS(TTM)-0.77
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.41
FCFYN/A
OCF(TTM)-0.37
OCFYN/A
SpS1.13
BVpS2.56
TBVpS2.56
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.44%
ROE -30.08%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-3.04%
ROA(5y)8.65%
ROE(3y)-5.56%
ROE(5y)18.57%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 17.19%
Cap/Sales 3.85%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.7
Quick Ratio 4.47
Altman-Z 0.48
F-Score2
WACC8.91%
ROIC/WACCN/A
Cap/Depr(3y)132.07%
Cap/Depr(5y)1512.98%
Cap/Sales(3y)8.02%
Cap/Sales(5y)16.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-193.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2944.35%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-16.05%
Revenue growth 3Y-44.02%
Revenue growth 5Y-4.59%
Sales Q2Q%9.16%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-94.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y39.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-37.79%
OCF growth 3YN/A
OCF growth 5YN/A